γδ T cells are a rare subset of T cells with the potential to exert anti-tumor functions in an MHC-independent manner through IFNγ, perforin, and granzyme B release [62], with anti-glioma activity demonstrated in vitro and in vivo [63, 64]. The gene discussed is PRF1; the disease is central nervous system cancer.